|
1
|
Warner JR and McIntosh KB: How common are
extraribosomal functions of ribosomal proteins? Mol Cell. 34:3–11.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lindstrom MS and Zhang Y: Ribosomal
protein S9 is a novel B23/NPM-binding protein required for normal
cell proliferation. J Biol Chem. 283:15568–15576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Volarevic S, Stewart MJ, Ledermann B,
Zilberman F, Terracciano L, Montini E, Grompe M, Kozma SC and
Thomas G: Proliferation, but not growth, blocked by conditional
deletion of 40S ribosomal protein S6. Science. 288:2045–2047. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He H and Sun Y: Ribosomal protein S27L is
a direct p53 target that regulates apoptosis. Oncogene.
26:2707–2716. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jang CY, Lee JY and Kim J: RpS3, a DNA
repair endonuclease and ribosomal protein, is involved in
apoptosis. FBS Lett. 560:81–85. 2004. View Article : Google Scholar
|
|
6
|
Hegde V, Wang M and Deutsch WA: Human
ribosomal protein S3 interacts with DNA base excision repair
proteins hAPE/Ref-1 and hOGG1. Biochemistry. 43:14211–14217. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anderson SJ, Lauritsen JP, Hartman MG,
Foushee AM, Lefebvre JM, Shinton SA, Gerhardt B, Hardy RR, Oravecz
T and Wiest DL: Ablation of ribosomal protein L22 selectively
impairs αβ T cell development by activation of a p53-dependent
checkpoint. Immunity. 26:759–772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhan Y, Melian NY, Pantoja M, Haines N,
Ruohola-Baker H, Bourque CW, Rao Y and Carbonetto S: Dystroglycan
and mitochondrial ribosomal protein L34 regulate differentiation in
the Drosophila eye. PLoS One. 5:e104882010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang W, Nag S, Zhang X, Wang MH, Wang H,
Zhou J and Zhang R: Ribosomal proteins and human diseases:
Pathogenesis, molecular mechanisms, and therapeutic implications.
Med Res Rev. 35:225–285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu M, Wang Y, Chen L, Pan B, Chen F, Fang
Y, Yu Z and Chen G: Down-regulation of ribosomal protein S15A mRNA
with a short hairpin RNA inhibits human hepatic cancer cell growth
in vitro. Gene. 536:84–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao Y, Liu Y, Lv X, Dong B, Wang F, Li J,
Zhang Q, Xu R and Xu Y: Down-regulation of ribosomal protein S15A
inhibits proliferation of human glioblastoma cells in vivo and in
vitro via AKT pathway. Tumour Biol. 37:4979–4990. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Fu J, Xue F, Ryu B, Zhang T,
Zhang S, Sun J, Xu X, Shen Z, Zheng L and Chen X: Knockdown of
ribosomal protein S15A induces human glioblastoma cell apoptosis.
World J Surg Oncol. 14:1292016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X, Shen L, Feng Y, Yu H, Wu X, Chang
J, Shen X, Qiao J and Wang J: Decreased expression of RPS15A
suppresses proliferation of lung cancer cells. Tumour Biol.
36:6733–6740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen J, Wei Y, Feng Q, Ren L, He G, Chang
W, Zhu D, Yi T, Lin Q, Tang W, et al: Ribosomal protein S15A
promotes malignant transformation and predicts poor outcome in
colorectal cancer through misregulation of p53 signaling pathway.
Int J Oncol. 48:1628–1638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Zhang G, Li X, Li B and Zhang X:
The effect of ribosomal protein S15a in lung adenocarcinoma. Peer
J. 4:e17922016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Capitanio U and Montorsi F: Renal cancer.
Lancet. 387:894–906. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abu Aboud O, Wettersten HI and Weiss RH:
Inhibition of PPARα induces cell cycle arrest and apoptosis, and
synergizes with glycolysis inhibition in kidney cancer cells. PLoS
One. 8:e711152013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu X, Xiong X and Sun Y: The role of
ribosomal proteins in the regulation of cell proliferation,
tumorigenesis, and genomic integrity. Sci China Life Sci.
59:656–672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brandsma AM, Jacobino SR, Meyer S, ten
Broeke T and Leusen JH: Fc receptor inside-out signaling and
possible impact on antibody therapy. Immunol Rev. 268:74–87. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Xie H, He D and Li L: Infiltrating
macrophages increase RCC epithelial mesenchymal transition (EMT)
and stem cell-like populations via AKT and mTOR signaling.
Oncotarget. 7:44478–44491. 2016.PubMed/NCBI
|
|
25
|
Guo H, Li Y, Tian T, Han L, Ruan Z, Liang
X, Wang W and Nan K: The role of cytoplasmic p57 in invasion of
hepatocellular carcinoma. BMC Gastroenterol. 15:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimizu T, Kamel WA, Yamaguchi-Iwai S,
Fukuchi Y, Muto A and Saya H: Calcitriol exerts an anti-tumor
effect in osteosarcoma by inducing the endoplasmic reticulum stress
response. Cancer Sci. 108:1793–1802. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Casey SC, Tong L, Li Y, Do R, Walz S,
Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M and Felsher
DW: MYC regulates the antitumor immune response through CD47 and
PD-L1. Science. 352:227–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsumoto M, Seike M, Noro R, Soeno C,
Sugano T, Takeuchi S, Miyanaga A, Kitamura K, Kubota K and Gemma A:
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in
small cell lung cancer. BMC Cancer. 15:2412015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pelengaris S, Khan M and Evan G: c-MYC:
More than just a matter of life and death. Nat Rev Cancer.
2:764–776. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishikawa M, Miyake H, Harada K and
Fujisawa M: Expression level of phosphorylated-4E-binding protein 1
in radical nephrectomy specimens as a prognostic predictor in
patients with metastatic renal cell carcinoma treated with
mammalian target of rapamycin inhibitors. Med Oncol. 31:7922014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nishikawa M, Miyake H, Harada K and
Fujisawa M: Expression of molecular markers associated with the
mammalian target of rapamycin pathway in nonmetastatic renal cell
carcinoma: Effect on prognostic outcomes following radical
nephrectomy. Urol Oncol. 32:49.e15–e21. 2014. View Article : Google Scholar
|
|
33
|
Qu Y, Zhao R, Wang H, Chang K, Yang X,
Zhou X, Dai B, Zhu Y, Shi G, Zhang H and Ye D: Phosphorylated 4EBP1
is associated with tumor progression and poor prognosis in Xp11.2
translocation renal cell carcinoma. Sci Rep. 6:235942016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu J, Chen J, Dong Z, Meyuhas O and Chen
JK: Phosphorylation of ribosomal protein S6 mediates compensatory
renal hypertrophy. Kidney Int. 87:543–556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dowling RJ, Topisirovic I, Alain T,
Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, Selvaraj
A, Liu Y, et al: mTORC1-mediated cell proliferation, but not cell
growth, controlled by the 4E-BPs. Science. 328:1172–1176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jones J, Otu H, Spentzos D, Kolia S, Inan
M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, et al: Gene
signatures of progression and metastasis in renal cell cancer. Clin
Cancer Res. 11:5730–5739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Higgins JP, Shinghal R, Gill H, Reese JH,
Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M and Brooks
JD: Gene expression patterns in renal cell carcinoma assessed by
complementary DNA microarray. Am J Pathol. 162:925–932. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yusenko MV, Kuiper RP, Boethe T, Ljungberg
B, van Kessel AG and Kovacs G: High-resolution DNA copy number and
gene expression analyses distinguish chromophobe renal cell
carcinomas and renal oncocytomas. BMC Cancer. 9:1522009. View Article : Google Scholar : PubMed/NCBI
|
